Top Markets
Coin of the day
Probi AB (publ) Probi AB (publ)

Probi AB (publ)

PROB
Rangering i aksjer #14013
Probi AB (publ) specializes in the research, development, manufacturing,... Probi AB (publ) specializes in the research, development, manufacturing, marketing, and distribution of probiotics for the health, pharmaceutical, and food sectors. The company's scientific endeavors primarily focus on areas such as gastrointestinal, digestive, immune, and bone health, as well as iron absorption, and the specific health requirements of children, women, and seniors. Their product range includes dietary supplements and various food and beverage applications, offered in diverse formats like capsules, tablets (including chewable), spheres, powders, and an array of drinks such as fruit drinks, shots, carbonated beverages, and recovery drinks. Probi's products are sold in approximately 40 countries globally. The company also fosters collaborations, including a partnership with Örebro University for exploring needle-free vaccines and with La Trobe University for a clinical trial assessing the effects of Probi Osteo in Australian women. Established in 1991 and headquartered in Lund, Sweden, Probi AB (publ) operates as a subsidiary of Symrise AG.
Aksjekurs
$38.87
Sist synkronisert: 2025-02-12
Markedsverdi
$442.88M
Endring (1 dag)
21.28%
Endring (1 år)
0.00%
Land
SE
Handel Probi AB (publ) (PROB)

Kategori

P/B-forhold for Probi AB (publ) (PROB)
P/B-forhold per 2026 TTM: 0
Ifølge Probi AB (publ) sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Probi AB (publ) fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter